During the past decade, Genetics Clinics Australia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Genetics Clinics Australia" are "Fragile X Syndrome" (3 trials) and "22Q Deletion Syndrome" (1 trials). Many other conditions were trialed in "Genetics Clinics Australia" in a lesser frequency.

Most popular intervention types in "Genetics Clinics Australia" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ZYN002 - Cannabidiol Transdermal Gel" (2 trials), "Placebo" (1 trials), "Placebo Transdermal Gel" (1 trials), "ZYN002" (1 trials) and "ZYN002 - transdermal gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Genetics Clinics Australia" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Genetics Clinics Australia". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Genetics Clinics Australia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Genetics Clinics Australia, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".